The Global Patient Monitoring Devices Market to Surpass USD

New York, USA, Oct. 18, 2022 (GLOBE NEWSWIRE) — The Global Patient Monitoring Devices Market to Surpass USD 56 Billion Mark by 2027 | DelveInsight

As per DelveInsight analysis in the patient monitoring devices market, the demand for these devices is projected to rise exponentially owing to the growing prevalence of various lifestyle-associated disorders and chronic disorders. Additionally, the outbreak of the COVID-19 pandemic has also fuelled the patient monitoring devices market.

DelveInsight’s Patient Monitoring Devices Market Insights report provides the current and forecast market, forthcoming device innovation, individual leading companies’ market shares, challenges, patient monitoring devices market drivers, barriers, and trends, and key patient monitoring devices companies in the market.

Key Takeaways from the Patient Monitoring Devices Market Report

• As per DelveInsight estimates, North America is anticipated to dominate the global patient monitoring devices market during the forecast period.  
• Notable patient monitoring devices companies such as Abbott, Masimo, Brain Scientific Inc., Koninklijke Philips N.V., Medtronic, Boston Scientific Corporation, GE Healthcare, Omron Corporation, Drägerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, Compumedics Limited, Dexcom, Inc., Nonin, BIOTRONIK, Natus Medical Incorporated., Hill-Rom Services, Inc., Getinge AB, SCHILLER, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Nihon Kohden Corporation, and several others are currently operating in the patient monitoring devices market.
• On November 01, 2021, Masimo launched the Dual SET® Pulse Oximetry for Root®, a highly versatile patient monitoring and connectivity hub. The first application of Dual SET® Oximetry is a significant advancement to Masimo SET®-guided critical congenital heart disease (CCHD) screening, with the CE marking and European launch of the Masimo SET® MOC-9® module and the addition of the Eve™ CCHD Newborn Screening…